Accessibility Tools
Category : Journal (knee) / Orthopaedics

Tranexamic acid (TXA) is commonly used in topical, oral, and intravenous (IV) forms to safely and effectively reduce blood loss and transfusions in patients undergoing primary total knee arthroplasty (TKA). [1-7] Less is known about the blood-sparing effects of TXA in revision TKA patients, who typically experience more blood loss than primary TKA patients.
Source : ICJR
On : 09-May-2019